Anti-inflammatory action

"Anti-inflammatory action" is not the name of a specific molecule, receptor, enzyme, or other canonical therapeutic target. Instead, it refers to the general property or effect of reducing inflammation in biological systems. This term describes the outcome of various drugs and molecules—such as nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, biologics targeting cytokines like TNF-alpha—but does not itself denote any single protein or gene product[3][4][2]. The anti-inflammatory action can be achieved by inhibiting enzymes like cyclooxygenase (COX), modulating transcription factors such as NF-kB and AP-1, interfering with cytokine signaling pathways including TNF-TNFR1/TNFR2 and TLR4/MD2 complexes, or suppressing immune cell activity[1][3][4]. Because "anti-inflammatory action" is an effect rather than a discrete molecular entity or drug target—and because it encompasses many different mechanisms and targets—it should not be treated as a canonical therapeutic target for structured data purposes.

Other names

Anti-inflammatory effectAnti-inflammationAnti-inflammatory activityAnti-inflammatory mechanism